Bayer is lobbying U.S. states to adjust their regulatory framework in its battle to wind down costly litigation over its weed killer glyphosate, the German chemicals company's CEO said in a draft speech released on Thursday.
Bayer CEO: targeting US state regulation to stem glyphosate costs
Glyphosate class action moves forward in Canada
Bayer defends safety of the herbicide, but legal costs may force withdrawal from U.S. market
Multiple law firms across the country – in Saskatchewan, Ontario, British Columbia and elsewhere – are now recruiting Canadians to join a class action lawsuit related to Roundup and cases of non-Hodgkin’s lymphoma.
Bayer renews bid for US Supreme Court to curb glyphosate cases
Bayer said on Friday it was again petitioning the U.S. Supreme Court to sharply limit legal claims that its Roundup herbicide causes cancer, seeking to avoid potentially billions of dollars in damages.
Bayer hit with $2 billion Roundup verdict in US state of Georgia cancer case
Bayer was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion (C$3.01 billion) to a plaintiff who claimed the company's Roundup weed killer caused his cancer, the plaintiff's law firms said late on Friday.
Bayer tells US it could halt Roundup weedkiller sales over legal risks
Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against product liability litigation.
Bayer projects improvement in 2026 after profit decline this year
Bayer on Wednesday raised the prospect of a return to earnings growth from 2026 after a decline this year, lifting its shares to a four-month high as its CEO somewhat allayed investor impatience with his turnaround efforts.
Bayer introduces FieldView Drive 2.0 at Crop Production Show 2025
Bayer used the Western Canadian Crop Production Show in Saskatoon this week to introduce Prairie farmers to its new FieldView Drive 2.0 digital system.
Bayer shareholders call on CEO to stem the tide of bad news
Some Bayer investors say CEO Bill Anderson should speed up turnaround efforts, including boosting efficiency and drug development, to restore confidence and revive the company's share price that hit 20-year lows after its shock warning this week.
Cash-strapped US farmers switch to generic crop chemicals, in blow to big manufacturers
U.S. farmers struggling with slumping incomes and depressed grain prices have been switching to cheaper generic pesticides and fungicides as they plan for spring planting next year, which market analysts said could hit the bottom lines of agrichemical companies like Bayer.
Bayer’s shares sink to 20-year low on 2025 earnings fall forecast
Bayer said on Tuesday that weak agricultural markets mean its earnings are likely to fall further next year, sparking a sharp fall in the German company's shares and piling pressure on its CEO to deliver on his turnaround efforts.
Cyber-Savvy Farmer
